Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-10-054139)

Filing Details

Accession Number:: 0001209191-10-054139
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-10 12:27:35
Reporting Period:: 2010-11-09

Filing Date:: 2010-11-10
Accepted Time:: 2010-11-10 12:27:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949858	Oncogenex Pharmaceuticals Inc.	OGXI	In Vitro & In Vivo Diagnostic Substances (2835)	954343413

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1486333	William Cameron Lawrence	400 - 1001 West Broadway Vancouver A1 V6H 4B1	Principal Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-11-09	650	$15.73	3,050	No	4	P	Indirect	RRSP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	RRSP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	475	Indirect	Spouse RRSP